[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334738-105":59,"doc-detail-334738-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","regulation-of-molecular-biomarkers-associated-with-the-progression-of-prostate-cancer","Regulation of Molecular Biomarkers Associated with the Progression of Prostate Cancer","","Androgen receptor signaling governs both normal and pathological prostate growth, making prostate cancer cell proliferation and survival initially reliant on androgen receptor activity. Treatment with androgen deprivation therapy drives the emergence of castration-resistant prostate cancer, accompanied by diverse molecular and cellular alterations. These include neuroendocrine features and multiple biomarkers, such as key transcription factors, signaling molecules, and receptor changes, reflecting tumor heterogeneity. The article highlights that genetic changes, therapies, and tumor microenvironment remodeling likely shape progression, while the origin of phenotypic and molecular shifts under specific treatment conditions remains incompletely defined.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/regulation-of-molecular-biomarkers-associated-with-the-progression-of-prostate-cancer/334738/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/regulation-of-molecular-biomarkers-associated-with-the-progression-of-prostate-cancer/334738.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is androgen receptor signaling important in prostate cancer progression?","Question",{"text":112,"@type":113},"Androgen receptor signaling regulates both normal and pathological prostate growth. Prostate cancer cell growth and survival are initially dependent on this pathway, so disrupting it with androgen deprivation therapy reshapes tumor behavior.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What triggers the development of castration-resistant prostate cancer after androgen deprivation therapy?",{"text":117,"@type":113},"Prolonged exposure to androgen deprivation therapy leads tumors to progress toward castration-resistant prostate cancer. The transition involves both androgen receptor–dependent and androgen receptor–independent resistance mechanisms.",{"name":119,"@type":110,"acceptedAnswer":120},"Which types of molecular biomarkers are associated with castration-resistant progression?",{"text":121,"@type":113},"The progression is linked to neuroendocrine features and multiple biomarkers, including transcription factors, signaling molecules, and receptor alterations. These biomarkers reflect molecular changes that support androgen-independent growth.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334738,1790155105,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Review  \nRegulation of Molecular Biomarkers Associated with the Progression of Prostate Cancer  \nMiguel Martin-Caraballo   \nCitation: Martin-Caraballo, M.  \nRegulation of Molecular Biomarkers Associated with the Progression of Prostate Cancer. Int. J. Mol. Sci. 2024, 25, 4171. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms25084171  \nAcademic Editor: Giovanni Luca Beretta  \nReceived: 11 March 2024  \nRevised: 1 April 2024  \nAccepted: 4 April 2024  \nPublished: 10 April 2024  \nCopyright: © 2024 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \nDepartment of Pharmaceutical Sciences, School of Pharmacy, University of Maryland Eastern Shore, Princess Anne, MD 21853, USA; [mmartin@umes.edu](mmartin@umes.edu)  \nAbstract: Androgen receptor signaling regulates the normal and pathological growth of the prostate. In particular, the growth and survival of prostate cancer cells is initially dependent on androgen receptor signaling. Exposure to androgen deprivation therapy leads to the development of castrationresistant prostate cancer. There is a multitude of molecular and cellular changes that occur in prostate tumor cells, including the expression of neuroendocrine features and various biomarkers, which promotes the switch of cancer cells to androgen-independent growth. These biomarkers include transcription factors (TP53, REST, BRN2, INSM1, c-Myc), signaling molecules (PTEN, Aurora kinases, retinoblastoma tumor suppressor, calcium-binding proteins), and receptors (glucocorticoid, androgen receptor-variant 7), among others. It is believed that genetic modifications, therapeutic treatments, and changes in the tumor microenvironment are contributing factors to the progression of prostate cancers with significant heterogeneity in their phenotypic characteristics. However, it is not well understood how these phenotypic characteristics and molecular modifications arise under specific treatment conditions. In this work, we summarize some of the most important molecular changes associated with the progression of prostate cancers and we describe some of the factors involved in these cellular processes.  \nKeywords: prostate cancer; neuroendocrine differentiation; castration-resistant prostate cancer; interleukin-6; signaling; biomarkers  \n1. Introduction  \nProstate cancer (PCa) is the most frequently diagnosed type of cancer and the second leading cause of cancer-related death among men [1,2] . The most common form of PCain men is adenocarcinoma (>90%), characterized by an elevated production of prostatespecific antigen (PSA). The growth of PCa is initially androgen-dependent [3] . Androgen deprivation therapies (ADTs) are usually effective in causing tumor regression. Androgen receptors (ARs) are nuclear receptors that bind to testosterone and other androgens [4] . In the prostate, testosterone is converted to 5a-dihydrotestosterone (DHT) by the enzyme 5α reductase. DHT has a higher affinity for the ARs than testosterone [5] . The binding of testosterone or DHT to the ARs results in the formation of a complex that can migrate to the nucleus in order to regulate the expression of androgen-inducible genes [4] . However, prolonged exposure to ADT results in the progression of prostate tumors to a castrationresistant prostate cancer (CRPC) with a poor clinical prognosis (Figure 1) . We should be aware that ADT does not result in a complete elimination of circulating androgens [6] . Furthermore, ADT has no effect on the levels of adrenal gland-produced androgens [7] . The molecular and cellular mechanisms involved in the transition of PCa to a castration-resistant phenotype are currently being explored in order to design better ","cbCaifcAru8dGoo2","https://ap.wps.com/l/cbCaifcAru8dGoo2","pdf",694608,15,"English","# Introduction\n## Androgen receptor signaling and androgen deprivation therapy\n## Mechanisms driving castration-resistant prostate cancer\n## Molecular changes and biomarkers in progression","[{\"question\":\"Why is androgen receptor signaling important in prostate cancer progression?\",\"answer\":\"Androgen receptor signaling regulates both normal and pathological prostate growth. Prostate cancer cell growth and survival are initially dependent on this pathway, so disrupting it with androgen deprivation therapy reshapes tumor behavior.\"},{\"question\":\"What triggers the development of castration-resistant prostate cancer after androgen deprivation therapy?\",\"answer\":\"Prolonged exposure to androgen deprivation therapy leads tumors to progress toward castration-resistant prostate cancer. The transition involves both androgen receptor–dependent and androgen receptor–independent resistance mechanisms.\"},{\"question\":\"Which types of molecular biomarkers are associated with castration-resistant progression?\",\"answer\":\"The progression is linked to neuroendocrine features and multiple biomarkers, including transcription factors, signaling molecules, and receptor alterations. These biomarkers reflect molecular changes that support androgen-independent growth.\"}]","Regulation of Molecular Biomarkers Associated with the Progression of Prostate Cancer | PDF",1790008073,38]